Related Experiment Video

Updated: Aug 24, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Highly active antiretroviral therapy in neonates and young infants

Givens Susan Bell1

  • 1NICU, All Children's Hospital, St. Petersburg, Florida, USA.

Neonatal Network : NN
|April 14, 2004
PubMed

Insights

Neonatal nurses will administer antiretroviral therapy to infants with HIV. Research is ongoing to understand drug effectiveness and safety in premature infants, crucial for optimal HIV management.

Area of Science:

  • Pediatric Infectious Diseases
  • Neonatal Pharmacology
  • Clinical Pharmacy

Background:

  • Early diagnosis of HIV in neonates and infants is improving.
  • HIV-infected infants often receive combination antiretroviral therapy (ART) to suppress viral replication and improve immune function.
  • Combination ART reduces the risk of drug resistance compared to monotherapy.

Purpose of the Study:

  • To highlight the evolving role of neonatal nurses in administering ART to infants.
  • To underscore the need for further research into the pharmacokinetics and long-term effects of ART in neonates, particularly premature infants.
  • To emphasize the importance of updated clinical guidelines and resources for managing HIV in infants.

Main Methods:

  • Pharmacokinetic studies of antiretroviral agents in neonates are being conducted under PACTG protocols.
  • Research is needed to specifically evaluate the pharmacokinetics of ART in premature infants.
  • Long-term studies are required to assess the effects of ART on growth and development in HIV-infected infants.

Main Results:

  • The pharmacokinetics of most antiretroviral agents in neonates are under investigation.
  • Specific dosing guidelines for antiretroviral agents in premature infants are largely unknown, except for zidovudine.
  • The long-term impact of ART on infant growth and development requires additional research.

Conclusions:

  • Knowledge regarding HIV management in infants is rapidly advancing.
  • Further research is essential to establish safe and effective ART regimens for all infant populations, especially preterm infants.
  • Healthcare providers should utilize updated resources, such as AIDSinfo.nih.gov, for current HIV management recommendations.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...